Absorption |
Blood-Brain Barrier | BBB+ | 0.9484 |
Human Intestinal Absorption | HIA+ | 0.9967 |
Caco-2 Permeability | Caco2+ | 0.5948 |
P-glycoprotein Substrate | Substrate | 0.6801 |
P-glycoprotein Inhibitor | Inhibitor | 0.8656 |
Inhibitor | 0.8432 |
Renal Organic Cation Transporter | Inhibitor | 0.6165 |
Distribution |
Subcellular localization | Mitochondria | 0.9031 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8634 |
CYP450 2D6 Substrate | Substrate | 0.8919 |
CYP450 3A4 Substrate | Substrate | 0.5304 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6781 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
CYP450 2D6 Inhibitor | Inhibitor | 0.8932 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
CYP450 3A4 Inhibitor | Inhibitor | 0.6667 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8226 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6092 |
Inhibitor | 0.7645 |
AMES Toxicity | Non AMES toxic | 0.8925 |
Carcinogens | Non-carcinogens | 0.8987 |
Fish Toxicity | High FHMT | 0.7956 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9804 |
Honey Bee Toxicity | Low HBT | 0.7564 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | II | 0.7270 |
Carcinogenicity (Three-class) | Non-required | 0.5044 |